vTv Therapeutics Inc. Stock Analysis & AI Score
vTv Therapeutics Inc. (VTVT) has an ST Score of 59.4 (B-), driven by its Profitability (A+) and held back by its Valuation (C). Analysts rate it Buy with a $42.00 price target (+36.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
vTv Therapeutics Inc. (VTVT) has an ST Score of 59.4 (B-), driven by its Profitability (A+) and held back by its Valuation (C). Analysts rate it Buy with a $42.00 price target (+36.7% upside).
- Strongest
- ProfitabilityA+
- Weakest
- ValuationC
All factor grades
- ProfitabilityA+
- Financial StrengthA+
- ForecastB
- GrowthB-
- MomentumC+
- ValuationC
- Piotroski2/9
Contact
VTVT stock: frequently asked questions
What is VTVT's ST Score?
vTv Therapeutics Inc. (VTVT) has an ST Score of 59.4 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is VTVT a buy, hold, or sell?
Analysts rate VTVT a Buy, with a price target of $42.00 (+36.7% vs the current price). Our ST Score grades it B- (59.4/100). The ST Score is a data-driven signal, not a recommendation.
What are VTVT's factor grades?
Valuation C, Profitability A+, Financial Strength A+, Momentum C+, Growth B-, Forecast B.
What is VTVT's valuation grade?
vTv Therapeutics Inc. (VTVT) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is VTVT's growth grade?
vTv Therapeutics Inc. (VTVT) earns a growth grade of B-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is VTVT's profitability grade?
vTv Therapeutics Inc. (VTVT) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is VTVT's financial strength grade?
vTv Therapeutics Inc. (VTVT) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for VTVT?
The average analyst price target for vTv Therapeutics Inc. (VTVT) is $42.00 from 14 analysts, which is +36.7% versus the recent price of $30.73.
What is VTVT's Piotroski score?
vTv Therapeutics Inc. (VTVT) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.